The data reported in this study add new important information, indicating that inhibitors of the PI3K/Akt/mTOR pathway can significantly revert the expression of the genes up- or down-regulated in NB hypoxic tumors, thus representing a potential target pathway to counteract the negative effects of hypoxia in NB. This evidence concerns the gene MTOR and neuroblastoma.